Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors

NCT00379340 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00379340
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00379340 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
Lead sponsor
Children's Oncology Group
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2007
Completion date
March 31, 2026
Enrollment
395 (actual)
Sites
227

Conditions

As the registry lists them; a condition with its own page is linked.

stage iii kidney wilms tumor, stage iv kidney wilms tumor